Navigation Links
Eurofins MWG Operon signs contract to supply oligonucleotides to Research Councils
Date:8/10/2010

Ebersberg, Germany, August 10, 2010 Eurofins MWG Operon, international market leader and expert for custom oligonucleotide synthesis and RCUK Shared Services Centre Limited (RCUK SSC Ltd) have signed a three year contract for the supply of synthetic DNA & RNA oligonucleotides. This long term contract builds on the relationship developed as a preferred supplier to the Medical Research Council (MRC) during the previous four years.

RCUK SSC Ltd has been set up by the seven Research Councils of the UK (RCUK) to provide centralised services to the Research Councils and their institutes in; human resources (HR), finance, procurement, Information Technology, Information Systems and grants processing. By adopting a shared services approach, the Research Councils are making financial savings, and are at the same time increasing their operational efficiency.

"We are very proud that RCUK SSC Ltd has selected Eurofins MWG Operon as one of their service providers of choice, on behalf of the UK's Research Councils and continues our business relationship" says Bruno Poddevin, Eurofins Senior Vice President, Genomic Services. "By signing the three year contract, RCUK SSC Ltd confirms their trust in our product quality and outstanding service with which Eurofins MWG Operon has identified itself for more than twenty years."

Richard Fowles, Category Manager with RCUK SSC Ltd commented, "We are very pleased to be able to announce Eurofins MWG Operon is to be one of our preferred suppliers of oligos. We feel that their great product offering will be of significant benefit to researchers."

Eurofins MWG Operon also provides best in class next generation sequencing services, Sanger sequencing, siRNA and gene synthesis services and is committed to continually optimizing and improving processes and product quality to ensure that they deliver their products and services in the fastest and most convenient manner possible.


'/>"/>

Contact: Dr. Jutta Huber
juttahuber@eurofins.com
49-809-282-89930
Eurofins MWG Operon
Source:Eurekalert

Page: 1

Related biology news :

1. Verizon Business to Provide Global IP for Eurofins Scientific
2. Eurofins MWG Operon and Genomatix launch strategic alliance
3. Eurofins MWG Operon and Genomatix developed most complete human exome array
4. bioMETRX, Inc. Signs Deal To Acquire Controlling Interest in Biometric Solutions, LLC
5. Unifying the animate and the inanimate designs of nature
6. University of Miami engineer designs stretchable electronics with a twist
7. Engineering technology pinpoints earliest signs of animal life
8. La Jolla Institute signs exclusive license agreement with Medimmune on major asthma discovery
9. UK robot sub searches for signs of melting 60 km into an Antarctic ice shelf cavity
10. Ben-Gurion University of the Negev signs collaborative contract with Bayer CropScience
11. WARF signs license agreement with Pfizer for human embryonic stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2016)... , June 3, 2016 ... Management) von Nepal ... und Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, ... führend in der Produktion und Implementierung von ... der Ausschreibung im Januar teilgenommen, aber Decatur ...
(Date:6/2/2016)... Perimeter Surveillance & Detection Systems, ... Infrastructure, Support & Other Service  The latest ... comprehensive analysis of the global Border Security market ... of $17.98 billion in 2016. Now: In ... in software and hardware technologies for advanced video surveillance. ...
(Date:5/20/2016)... , May 20, 2016  VoiceIt is excited ... with VoicePass. By working together, VoiceIt ...  Because VoiceIt and VoicePass take slightly different approaches ... increases both security and usability. ... about this new partnership. "This marketing ...
Breaking Biology News(10 mins):
(Date:6/22/2016)... Research and Markets has announced the addition of the ... The global biomarkers market has ... The market is expected to grow at a five-year compound annual ... $50.6 billion in 2015 to $96.6 billion in 2020. ... to 2020) are discussed. As well, new products approved in 2013 ...
(Date:6/22/2016)... 2016   StockNewsNow.com , The Official MicroCap News ... Nader Pourhassan , President & CEO of CytoDyn ... clinical development and potential commercialization of humanized monoclonal antibodies ... to the company,s website (see here: www.CytoDyn.com ). ... th , 2016, at the LD Micro Invitational in ...
(Date:6/22/2016)... --  ViaCyte, Inc. , a privately-held regenerative medicine company ... for the treatment of diabetes in clinical-stage development, today ... 2016, the Global Stem Cell Event, is taking place ... Francisco.    ... Focus Session: Tools for Basic and Applied Stem Cell ...
(Date:6/22/2016)... ... June 22, 2016 , ... ... spotlight on immigrant achievements and contributions to North Texas and the nation, recently ... from the immigrant community to the civic and economic vitality of North Texas. ...
Breaking Biology Technology: